Today: 16 April 2026
Taylor Wimpey share price ticks up as Help to Buy talk keeps UK builders in play
12 February 2026
1 min read

Taylor Wimpey share price ticks up as Help to Buy talk keeps UK builders in play

London, February 12, 2026, 09:40 GMT — Regular session

  • Taylor Wimpey shares ticked up in early London trading, following Wednesday’s strong surge.
  • Speculation around a refreshed Help to Buy-style scheme has sent UK housebuilders climbing.
  • Investors look to policy specifics and Taylor Wimpey’s March results, hoping for clearer direction.

Shares of Taylor Wimpey edged up 0.4% to 115.85 pence by 0925 GMT on Thursday, on the heels of a hefty 4.9% gain Wednesday that saw over 54 million shares traded. The move keeps momentum going for UK housebuilders after the sector’s strong rally a day earlier.

Speculation is swirling that the Labour government could revive Help to Buy, the state-backed scheme aimed at boosting financing for new-build homes. RBC’s Anthony Codling and his team flagged in a note that some of the biggest beneficiaries would likely be mainstream housebuilders with a strong footprint in the South and South East.

Why it matters now: Housebuilder stocks are moving on politics and interest rates as much as fundamentals. If first-time buyers get real help, demand can swing quickly—and markets usually factor that in before the details emerge.

Still, there’s nothing official yet—and investors have seen this story play out. If the scheme ends up diluted, eligibility rules tighten, or the rollout drags on, enthusiasm could fade fast. That risk only grows if mortgage affordability fails to rebound as expected.

The sector’s showing some cracks. Barratt Redrow slashed its interim dividend after reporting a 13.6% drop in adjusted pre-tax profit for the first half, squeezed by building costs outpacing gains in house prices. CEO David Thomas put it this way: “We don’t need significant house-price inflation to maintain margins.” Reuters

Taylor Wimpey has told investors not to count on a simple, steady rebound. Back in January, the builder projected its operating profit margin would slip in 2026 from the 11% expected in 2025, and cut its 2025 operating profit guidance to roughly £420 million. CEO Jennie Daly described first-time buyer demand as “muted.” Oli Creasey at Quilter Cheviot added that the outlook for further weakness “will not be what the market was hoping to see.” Reuters

This week brought a minor corporate disclosure: a filing revealed Daly and finance director Chris Carney picked up modest amounts of shares via the company’s Share Incentive Plan, an all-staff scheme. PDMR status means these senior execs have to report their transactions under UK market-abuse regulations.

Right now, Help to Buy headlines are driving the action, with dividends and build-cost inflation lurking as the variables that could tip things. A single negative affordability number—or yet another alert on margins—could throw the rally off course.

The next key moment for Taylor Wimpey comes with its full-year numbers on March 5. Investors want fresh 2026 guidance, plus any signs of how demand is shaping up for the spring selling season.

Stock Market Today

  • Urban Edge Properties Valuation Analysis Amid Share Price Surge
    April 15, 2026, 9:35 PM EDT. Urban Edge Properties (UE) has gained about 14.79% in the last 3 months and 24.58% over the past year, generating fresh valuation interest. The stock closed recently at $21.42, slightly below its assessed fair value of $22.14, suggesting a modest undervaluation. Analysts note redevelopment projects and signed but not open leases could boost net operating income (NOI) and future cash flow. However, the firm's price-to-earnings (P/E) ratio of 28.9x exceeds the U.S. Retail REIT sector average, raising concerns over limited margin of safety amid expected revenue and earnings declines. Further risks include tenant bankruptcies and market slowdowns in concentrated Northeast regions impacting occupancy and rents. Investors should weigh these factors as momentum builds around UE's stock price.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Uber stock slides toward $71 after hours as Baidu robotaxi Dubai launch, Lyft stumble keep traders wary
Previous Story

Uber stock slides toward $71 after hours as Baidu robotaxi Dubai launch, Lyft stumble keep traders wary

VNET Group stock price jumps in premarket after Jefferies call; what investors watch next
Next Story

VNET Group stock price jumps in premarket after Jefferies call; what investors watch next

Go toTop